Lifevantage Corporation Common Stock (Delaware) (LFVN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, LFVN trades at $5.23 with a market cap of $65.48M and a P/E ratio of 6.55. LFVN moved -0.38% today. Year to date, LFVN is -13.79%; over the trailing twelve months it is -60.38%. Its 52-week range spans $3.90 to $27.38. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces LFVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LifeVantage Q3 Revenue Slumps 25% to $43.7M as Dividend Rises 11%: LifeVantage reported Q3 revenue of $43.7 million, down 25.2% year-over-year, with net income per diluted share falling to $0.11 from $0.26 and adjusted EBITDA halving to $3.2 million. The board approved an 11% hike in its quarterly cash dividend to $0.05 per share, payable June 15 to shareholders of record June 1.
| Metric | Value |
|---|---|
| Price | $5.23 |
| Market Cap | $65.48M |
| P/E Ratio | 6.55 |
| EPS | $0.80 |
| Dividend Yield | 0.05% |
| 52-Week High | $27.38 |
| 52-Week Low | $3.90 |
| Volume | 3 |
| Avg Volume | 0 |
| Revenue (TTM) | $228.53M |
| Net Income | $9.80M |
| Gross Margin | 80.37% |
1 analysts cover LFVN: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.